Age groups | Population | Susceptible | Prevalencea | On ARV treatmenta | Treatment shortfallb |
---|---|---|---|---|---|
10–19 | 10 264 690 | 9 982 612 | 282 078 | 78 176 | 163 605 |
20–29 | 11 010 305 | 9 386 287 | 1 624 018 | 411 831 | 941 930 |
30–39 | 9 008 794 | 6 521 402 | 2 487 392 | 775 604 | 1 442 687 |
40–49 | 4 479 445 | 3 329 718 | 1 149 727 | 358 501 | 666 842 |
50–59 | 3 367 397 | 2 883 570 | 483 827 | 204 740 | 280 620 |
60+ | 3 665 571 | 3 534 983 | 130 588 | 55 260 | 75 741 |
Totals | 41 796 202 | 35 638 572 | 6 157 630 | 1 884 112 | 3 571 425 |